Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

R.C. Coombes; L.S. Kilburn; C.F. Snowdon; R. Paridaens; R.E. Coleman; S.E. Jones; J. Jassem; C.J. Van de Velde; T. Delozier; I. Alvarez; L. Del Mastro; O. Ortmann; K. Diedrich; A.S. Coates; E. Bajetta; S.B. Holmberg; D. Dodwell; E. Mickiewicz; J. Andersen; P.E. Lonning; G. Coccini; J. Forbes; M. Castiglione; N.S. Stuart; A. Stewart; L.J. Fallowfield; G. Bertelli; E. Hall; R.G. Bogle; M. Carpentieri; E. Colajori; M. Subar; E. Ireland; J.M. Bliss

doi:10.1016/S0140-6736(07)60200-1

Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

R.C. Coombes
, L.S. Kilburn
, C.F. Snowdon
, R. Paridaens
, R.E. Coleman
, S.E. Jones
, J. Jassem
, C.J. Van de Velde
, T. Delozier
, I. Alvarez
, L. Del Mastro
, O. Ortmann
, K. Diedrich
, A.S. Coates
, E. Bajetta
, S.B. Holmberg
, D. Dodwell
, E. Mickiewicz
, J. Andersen
, P.E. Lonning

G. Coccini, J. Forbes, M. Castiglione, N.S. Stuart, A. Stewart, L.J. Fallowfield, G. Bertelli, E. Hall, R.G. Bogle, M. Carpentieri, E. Colajori, M. Subar, E. Ireland, J.M. Bliss

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	559-570
Journal	The Lancet
Volume	369
Issue number	9561
DOIs	https://doi.org/10.1016/S0140-6736(07)60200-1
Publication status	Published - 1 Feb 2007

Keywords

MEDICINE
GENERAL & INTERNAL

Access to Document

10.1016/S0140-6736(07)60200-1

Cite this

Coombes, R. C., Kilburn, L. S., Snowdon, C. F., Paridaens, R., Coleman, R. E., Jones, S. E., Jassem, J., Van de Velde, C. J., Delozier, T., Alvarez, I., Del Mastro, L., Ortmann, O., Diedrich, K., Coates, A. S., Bajetta, E., Holmberg, S. B., Dodwell, D., Mickiewicz, E., Andersen, J., ... Bliss, J. M. (2007). Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. The Lancet, 369(9561), 559-570. https://doi.org/10.1016/S0140-6736(07)60200-1

@article{0f5ba21c18914752aab4ac898cf0ea03,

title = "Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.",

keywords = "MEDICINE, GENERAL \& INTERNAL",

author = "R.C. Coombes and L.S. Kilburn and C.F. Snowdon and R. Paridaens and R.E. Coleman and S.E. Jones and J. Jassem and \{Van de Velde\}, C.J. and T. Delozier and I. Alvarez and \{Del Mastro\}, L. and O. Ortmann and K. Diedrich and A.S. Coates and E. Bajetta and S.B. Holmberg and D. Dodwell and E. Mickiewicz and J. Andersen and P.E. Lonning and G. Coccini and J. Forbes and M. Castiglione and N.S. Stuart and A. Stewart and L.J. Fallowfield and G. Bertelli and E. Hall and R.G. Bogle and M. Carpentieri and E. Colajori and M. Subar and E. Ireland and J.M. Bliss",

year = "2007",

month = feb,

day = "1",

doi = "10.1016/S0140-6736(07)60200-1",

language = "English",

volume = "369",

pages = "559--570",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier BV",

number = "9561",

}

Coombes, RC, Kilburn, LS, Snowdon, CF, Paridaens, R, Coleman, RE, Jones, SE, Jassem, J, Van de Velde, CJ, Delozier, T, Alvarez, I, Del Mastro, L, Ortmann, O, Diedrich, K, Coates, AS, Bajetta, E, Holmberg, SB, Dodwell, D, Mickiewicz, E, Andersen, J, Lonning, PE, Coccini, G, Forbes, J, Castiglione, M, Stuart, NS, Stewart, A, Fallowfield, LJ, Bertelli, G, Hall, E, Bogle, RG, Carpentieri, M, Colajori, E, Subar, M, Ireland, E & Bliss, JM 2007, 'Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.', The Lancet, vol. 369, no. 9561, pp. 559-570. https://doi.org/10.1016/S0140-6736(07)60200-1

TY - JOUR

T1 - Survival and safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.

AU - Coombes, R.C.

AU - Kilburn, L.S.

AU - Snowdon, C.F.

AU - Paridaens, R.

AU - Coleman, R.E.

AU - Jones, S.E.

AU - Jassem, J.

AU - Van de Velde, C.J.

AU - Delozier, T.

AU - Alvarez, I.

AU - Del Mastro, L.

AU - Ortmann, O.

AU - Diedrich, K.

AU - Coates, A.S.

AU - Bajetta, E.

AU - Holmberg, S.B.

AU - Dodwell, D.

AU - Mickiewicz, E.

AU - Andersen, J.

AU - Lonning, P.E.

AU - Coccini, G.

AU - Forbes, J.

AU - Castiglione, M.

AU - Stuart, N.S.

AU - Stewart, A.

AU - Fallowfield, L.J.

AU - Bertelli, G.

AU - Hall, E.

AU - Bogle, R.G.

AU - Carpentieri, M.

AU - Colajori, E.

AU - Subar, M.

AU - Ireland, E.

AU - Bliss, J.M.

PY - 2007/2/1

Y1 - 2007/2/1

KW - MEDICINE

KW - GENERAL & INTERNAL

U2 - 10.1016/S0140-6736(07)60200-1

DO - 10.1016/S0140-6736(07)60200-1

M3 - Article

SN - 0140-6736

VL - 369

SP - 559

EP - 570

JO - The Lancet

JF - The Lancet

IS - 9561

ER -